APP and Alzheimer disease: SNX32 is associated with a higher risk of Alzheimer’s disease (Kibinge et al., 2020; Ou et al., 2021), and increased SNX33 expression reduces endocytosis of amyloid precursor protein (Takada-Takatori, 2021).